American Society of Hirudotherapy

Antithrombotic pharmacodynamics and metabolomics study in raw and processed products of Whitmania pigra Whitman

Pharmacology/metabolomics published in Heliyon (2024)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Research reportSalivary PharmacologyKui H et al. · Heliyon, 2024

Abstract

OBJECTIVE: As a traditional Chinese medicine, leech has obvious pharmacological activities in anticoagulantion and antithrombosis. Whitmania pigra Whitman (WP) is the most commonly used leech in the Chinese market. It is often used in clinical applications after high-temperature processing by talcum powder to remove the fishy taste and facilitate crushing. The anticoagulant and thrombolytic active ingredients are protein and polypeptide, which may denaturate and lose activity after high-temperature processing. The rationality of its processing has been questioned in recent years. This study aims to investigate the effect of talcum powder scalding on the antithrombotic activity of WP in vivo and to discuss its pharmacodynamic mechanism in vivo. METHODS: Raw and talcum-powdered processed WP were administered intragastrically for 14 days, and carrageenan was injected intraperitoneally to prepare a mouse model of tail vein thrombosis. The incidence rate of tail vein thrombosis and the thrombus area under pathological tissue sections were calculated to evaluate the antithrombotic effect between raw and processed WP. Non-targeted metabolomics was conducted using UPLC-Q-TOF/MS technology to analyze the changes of small molecule metabolites in the body after administration of WP. RESULTS: After intragastric administration, both the raw product and the processed product of WP could inhibit the thrombosis induced by carrageenan, and the processed product had a more apparent antithrombotic effect than the raw product. The administration of WP could regulate the changes of some small molecular metabolites, such as amino acids, lipids, and steroids, in Sphingolipid metabolism and Glycerophospholipid metabolism. CONCLUSIONS: Based on the results of pharmacodynamics and metabolomics, processed WP will not reduce the antithrombotic activity of WP. This study provided a scientific basis for the rational use of leeches.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Summary

In a mouse carrageenan-induced tail-vein thrombosis model, both raw and talcum-processed Whitmania pigra reduced thrombosis incidence after 14 days of intragastric dosing, with the processed product more effective. WP administration also altered small-molecule metabolites in sphingolipid and glycerophospholipid metabolism pathways.

Why This Matters for Hirudotherapy

This study compared the in vivo antithrombotic effects of raw versus processed (talcum powder scalded) products of the traditional Chinese medicine leech Whitmania pigra. Using a mouse model of tail vein thrombosis, the researchers found that both forms inhibited thrombosis, with the processed product exhibiting a more apparent effect, alongside changes in specific metabolic pathways. The research evaluates the pharmacodynamic consistency and metabolic mechanisms of leech preparations, addressing quality concerns in traditional leech medicine. This is an animal study evaluating orally administered leech extracts, which is distinct from live medicinal leech therapy.

Citation

Reference (Vancouver style)

Kui H, Lei Y, Jia C, Xin Q, Tursun R, Zhong M, et al. Antithrombotic pharmacodynamics and metabolomics study in raw and processed products of Whitmania pigra Whitman. Heliyon. 2024;10(7):e27828. doi:10.1016/j.heliyon.2024.e27828. PMID: 38596067

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 26, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.